Prevalence of Primary Drug Resistance Against HIV-1 Integrase Inhibitors in Canada

被引:22
作者
Ji, Hezhao [1 ,2 ]
Patterson, Aileen [1 ]
Taylor, Tracy [1 ]
Rank, Claudia [3 ]
Halverson, Jessica [3 ]
Capina, Rupert [1 ]
Brooks, James [1 ]
Sandstrom, Paul [1 ,2 ]
机构
[1] Publ Hlth Agcy Canada, JC Wilt Infect Dis Res Ctr, Natl Microbiol Lab, Winnipeg, MB, Canada
[2] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada
[3] Publ Hlth Agcy Canada, Surveillance & Epidemiol Div, Ottawa, ON, Canada
关键词
TREATMENT-EXPERIENCED PATIENTS; TREATMENT-NAIVE PATIENTS; TWICE-DAILY RALTEGRAVIR; NON-INFERIORITY; DOUBLE-BLIND; DOLUTEGRAVIR; INFECTION; ELVITEGRAVIR; MUTATIONS; EFFICACY;
D O I
10.1097/QAI.0000000000001649
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:E1 / E3
页数:3
相关论文
共 26 条
[1]  
[Anonymous], 2016, WHATS NEW HIV TREATM
[2]  
[Anonymous], GUID US ANT AG AD AD
[3]  
[Anonymous], 2015, FAST TRACK END AIDS
[4]   Polymorphic substitution E157Q in HIV-1 integrase increases R263K-mediated dolutegravir resistance and decreases DNA binding activity [J].
Anstett, Kaitlin ;
Cutillas, Vincent ;
Fusco, Robert ;
Mesplede, Thibault ;
Wainberg, Mark A. .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2016, 71 (08) :2083-2088
[5]   Drug Resistance Mutations for Surveillance of Transmitted HIV-1 Drug-Resistance: 2009 Update [J].
Bennett, Diane E. ;
Camacho, Ricardo J. ;
Otelea, Dan ;
Kuritzkes, Daniel R. ;
Fleury, Herve ;
Kiuchi, Mark ;
Heneine, Walid ;
Kantor, Rami ;
Jordan, Michael R. ;
Schapiro, Jonathan M. ;
Vandamme, Anne-Mieke ;
Sandstrom, Paul ;
Boucher, Charles A. B. ;
van de Vijver, David ;
Rhee, Soo-Yon ;
Liu, Tommy F. ;
Pillay, Deenan ;
Shafer, Robert W. .
PLOS ONE, 2009, 4 (03)
[6]   HIV-1 Integrase Inhibitor Resistance and Its Clinical Implications [J].
Blanco, Jose-Luis ;
Varghese, Vici ;
Rhee, Soo-Yon ;
Gatell, Jose M. ;
Shafer, Robert W. .
JOURNAL OF INFECTIOUS DISEASES, 2011, 203 (09) :1204-1214
[7]   Dolutegravir versus raltegravir in antiretroviral-experienced, integrase-inhibitor-naive adults with HIV: week 48 results from the randomised, double-blind, non-inferiority SAILING study [J].
Cahn, Pedro ;
Pozniak, Anton L. ;
Mingrone, Horacio ;
Shuldyakov, Andrey ;
Brites, Carlos ;
Andrade-Villanueva, Jaime F. ;
Richmond, Gary ;
Beltran Buendia, Carlos ;
Fourie, Jan ;
Ramgopal, Moti ;
Hagins, Debbie ;
Felizarta, Franco ;
Madruga, Jose ;
Reuter, Tania ;
Newman, Tamara ;
Small, Catherine B. ;
Lombaard, John ;
Grinsztejn, Beatriz ;
Dorey, David ;
Underwood, Mark ;
Griffith, Sandy ;
Min, Sherene .
LANCET, 2013, 382 (9893) :700-708
[8]   Elvitegravir: a once daily alternative to raltegravir [J].
Desimmie, Belete Ayele ;
Schrifvers, Rik ;
Debyser, Zeger .
LANCET INFECTIOUS DISEASES, 2012, 12 (01) :3-5
[9]   Efficacy and safety of raltegravir for treatment of HIV for 5 years in the BENCHMRK studies: final results of two randomised, placebo-controlled trials [J].
Eron, Joseph J. ;
Cooper, David A. ;
Steigbigel, Roy T. ;
Clotet, Bonaventura ;
Gatell, Jose M. ;
Kumar, Princy N. ;
Rockstroh, Jurgen K. ;
Schechter, Mauro ;
Markowitz, Martin ;
Yeni, Patrick ;
Loutfy, Mona R. ;
Lazzarin, Adriano ;
Lennox, Jeffrey L. ;
Strohmaier, Kim M. ;
Wan, Hong ;
Barnard, Richard J. O. ;
Nguyen, Bach-Yen T. ;
Teppler, Hedy .
LANCET INFECTIOUS DISEASES, 2013, 13 (07) :587-596
[10]   Cross-resistance to elvitegravir and dolutegravir in 502 patients failing on raltegravir: a French national study of raltegravir-experienced HIV-1-infected patients [J].
Fourati, Slim ;
Charpentier, Charlotte ;
Amiel, Corinne ;
Morand-Joubert, Laurence ;
Reigadas, Sandrine ;
Trabaud, Mary-Anne ;
Delaugerre, Constance ;
Nicot, Florence ;
Rodallec, Audrey ;
Maillard, Anne ;
Mirand, Audrey ;
Jeulin, Helene ;
Montes, Brigitte ;
Barin, Francis ;
Bettinger, Dominique ;
Le Guillou-Guillemette, Helene ;
Vallet, Sophie ;
Signori-Schmuck, Anne ;
Descamps, Diane ;
Calvez, Vincent ;
Flandre, Philippe ;
Marcelin, Anne-Genevieve .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2015, 70 (05) :1507-1512